| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Division of Immunology, Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720; and
The Jackson Laboratory, Bar Harbor, ME 04609
Minor histocompatibility (H) Ags elicit T cell responses and thereby cause chronic graft rejection and graft-vs-host disease among MHC identical individuals. Although numerous independent H loci exist in mice of a given MHC haplotype, certain H Ags dominate the immune response and are thus of considerable conceptual and therapeutic importance. To identify these H Ags and their genes, lacZ-inducible CD8+ T cell hybrids were generated by immunizing C57BL/6 (B6) mice with MHC identical BALB.B spleen cells. The cDNA clones encoding the precursor for the antigenic peptide/Kb MHC class I complex were isolated by expression cloning using the BCZ39.84 T cell as a probe. The cDNAs defined a new H locus (termed H60), located on mouse chromosome 10, and encoded a novel protein that contains the naturally processed octapeptide LTFNYRNL (LYL8) presented by the Kb MHC molecule. Southern blot analysis revealed that the H60 locus was polymorphic among the BALB and the B6 strains. However, none of the H60 transcripts expressed in the donor BALB spleen were detected in the host B6 strain. The expression and immunogenicity of the LYL8/Kb complex in BALB.B and CXB recombinant inbred strains strongly suggested that the H60 locus may account for one of the previously described antigenic activity among these strains. The results establish the source of an immunodominant autosomal minor H Ag that, by its differential transcription in the donor vs the host strains, provides a novel peptide/MHC target for host CD8+ T cells.
This article has been cited by other articles:
|
|
 |
|
  T. M. Cao, L. C. Lazzeroni, S. Tsai, W. W. Pang, A. Kao, N. J. Camp, A. Thomas, and J. A. Shizuru Identification of a Major Susceptibility Locus for Lethal Graft-versus-Host Disease in MHC-Matched Mice J. Immunol., July 1, 2009; 183(1): 462 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Ryu, K. M. Jung, H. S. Yoo, T. W. Kim, S. Kim, J. Chang, and E. Y. Choi Cognate CD4 help is essential for the reactivation and expansion of CD8 memory T cells directed against the hematopoietic cell-specific dominant minor histocompatibility antigen, H60 Blood, April 30, 2009; 113(18): 4273 - 4280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Mace, S. J. Monkley, D. R. Critchley, and F. Takei A Dual Role for Talin in NK Cell Cytotoxicity: Activation of LFA-1-Mediated Cell Adhesion and Polarization of NK Cells J. Immunol., January 15, 2009; 182(2): 948 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kanaseki and N. Shastri Endoplasmic Reticulum Aminopeptidase Associated with Antigen Processing Regulates Quality of Processed Peptides Presented by MHC Class I Molecules J. Immunol., November 1, 2008; 181(9): 6275 - 6282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Germain, E. Campigna, I. Salhi, S. Morisseau, I. Navarro-Teulon, J.-P. Mach, A. Pelegrin, and B. Robert Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein Protein Eng. Des. Sel., November 1, 2008; 21(11): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Guo, A. Samarakoon, B. Vanhaesebroeck, and S. Malarkannan The p110{delta} of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation J. Exp. Med., September 29, 2008; 205(10): 2419 - 2435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Takada, S. Yoshida, M. Kajikawa, Y. Miyatake, U. Tomaru, M. Sakai, H. Chiba, K. Maenaka, D. Kohda, K. Fugo, et al. Two Novel NKG2D Ligands of the Mouse H60 Family with Differential Expression Patterns and Binding Affinities to NKG2D J. Immunol., February 1, 2008; 180(3): 1678 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ito, T. Kanai, T. Totsuka, R. Okamoto, K. Tsuchiya, Y. Nemoto, A. Yoshioka, T. Tomita, T. Nagaishi, N. Sakamoto, et al. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G199 - G207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Malarkannan, J. Regunathan, H. Chu, S. Kutlesa, Y. Chen, H. Zeng, R. Wen, and D. Wang Bcl10 Plays a Divergent Role in NK Cell-Mediated Cytotoxicity and Cytokine Generation J. Immunol., September 15, 2007; 179(6): 3752 - 3762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. de Witte, M. Toebes, J.-Y. Song, M. C. Wolkers, and T. N. M. Schumacher Effective graft depletion of MiHAg T-cell specificities and consequences for graft-versus-host disease Blood, May 1, 2007; 109(9): 3830 - 3838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, F. M. Ellison, M. A. Eckhaus, A. L. Smith, K. Keyvanfar, R. T. Calado, and N. S. Young Minor Antigen H60-Mediated Aplastic Anemia Is Ameliorated by Immunosuppression and the Infusion of Regulatory T Cells J. Immunol., April 1, 2007; 178(7): 4159 - 4168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Regunathan, Y. Chen, S. Kutlesa, X. Dai, L. Bai, R. Wen, D. Wang, and S. Malarkannan Differential and Nonredundant Roles of Phospholipase C{gamma}2 and Phospholipase C{gamma}1 in the Terminal Maturation of NK Cells J. Immunol., October 15, 2006; 177(8): 5365 - 5376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lenac, M. Budt, J. Arapovic, M. Hasan, A. Zimmermann, H. Simic, A. Krmpotic, M. Messerle, Z. Ruzsics, U. H. Koszinowski, et al. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60 J. Exp. Med., August 7, 2006; 203(8): 1843 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Brickner, A. M. Evans, J. K. Mito, S. M. Xuereb, X. Feng, T. Nishida, L. Fairfull, R. E. Ferrell, K. A. Foon, D. F. Hunt, et al. The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL Blood, May 1, 2006; 107(9): 3779 - 3786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Bui, L. N. Carayannopoulos, L. L. Lanier, W. M. Yokoyama, and R. D. Schreiber IFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors J. Immunol., January 15, 2006; 176(2): 905 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Wettstein, N. D. Borson, J. G. Park, K. T. McNallan, and A. M. Reed Cysteine-Tailed Class I-Binding Peptides Bind to CpG Adjuvant and Enhance Primary CTL Responses J. Immunol., September 15, 2005; 175(6): 3681 - 3689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhou, Y. Luo, J.-f. Lo, C. D. Kaplan, M. Mizutani, N. Mizutani, J.-D. Lee, F. J. Primus, J. C. Becker, R. Xiang, et al. DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor PNAS, August 2, 2005; 102(31): 10846 - 10851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hasan, A. Krmpotic, Z. Ruzsics, I. Bubic, T. Lenac, A. Halenius, A. Loewendorf, M. Messerle, H. Hengel, S. Jonjic, et al. Selective Down-Regulation of the NKG2D Ligand H60 by Mouse Cytomegalovirus m155 Glycoprotein J. Virol., March 1, 2005; 79(5): 2920 - 2930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Krmpotic, M. Hasan, A. Loewendorf, T. Saulig, A. Halenius, T. Lenac, B. Polic, I. Bubic, A. Kriegeskorte, E. Pernjak-Pugel, et al. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145 J. Exp. Med., January 18, 2005; 201(2): 211 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Regunathan, Y. Chen, D. Wang, and S. Malarkannan NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors Blood, January 1, 2005; 105(1): 233 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Lodoen, G. Abenes, S. Umamoto, J. P. Houchins, F. Liu, and L. L. Lanier The Cytomegalovirus m155 Gene Product Subverts Natural Killer Cell Antiviral Protection by Disruption of H60-NKG2D Interactions J. Exp. Med., October 18, 2004; 200(8): 1075 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yoshimura, R. Yadav, G. J. Christianson, W. U. Ajayi, D. C. Roopenian, and S. Joyce Duration of Alloantigen Presentation and Avidity of T Cell Antigen Recognition Correlate with Immunodominance of CTL Response to Minor Histocompatibility Antigens J. Immunol., June 1, 2004; 172(11): 6666 - 6674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Friese, M. Platten, S. Z. Lutz, U. Naumann, S. Aulwurm, F. Bischof, H.-J. Buhring, J. Dichgans, H.-G. Rammensee, A. Steinle, et al. MICA/NKG2D-Mediated Immunogene Therapy of Experimental Gliomas Cancer Res., December 15, 2003; 63(24): 8996 - 9006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schott, R. Bonasio, and H. L. Ploegh Elimination In Vivo of Developing T Cells by Natural Killer Cells J. Exp. Med., October 20, 2003; 198(8): 1213 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Cao, B. Lo, E. A. Ranheim, F. C. Grumet, and J. A. Shizuru Variable hematopoietic graft rejection and graft-versus-host disease in MHC-matched strains of mice PNAS, September 30, 2003; 100(20): 11571 - 11576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Schwab, K. C. Li, C. Kang, and N. Shastri Constitutive Display of Cryptic Translation Products by MHC Class I Molecules Science, September 5, 2003; 301(5638): 1367 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Murata, E. H. Warren, and S. R. Riddell A Human Minor Histocompatibility Antigen Resulting from Differential Expression due to a Gene Deletion J. Exp. Med., May 19, 2003; 197(10): 1279 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lodoen, K. Ogasawara, J. A. Hamerman, H. Arase, J. P. Houchins, E. S. Mocarski, and L. L. Lanier NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules J. Exp. Med., May 19, 2003; 197(10): 1245 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yadav, Y. Yoshimura, A. Boesteanu, G. J. Christianson, W. U. Ajayi, R. Shashidharamurthy, A. K. Stanic, D. C. Roopenian, and S. Joyce The H4b Minor Histocompatibility Antigen Is Caused by a Combination of Genetically Determined and Posttranslational Modifications J. Immunol., May 15, 2003; 170(10): 5133 - 5142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Rabinovich, J. Li, J. Shannon, R. Hurren, J. Chalupny, D. Cosman, and R. G. Miller Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells J. Immunol., April 1, 2003; 170(7): 3572 - 3576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Y. Choi, G. J. Christianson, Y. Yoshimura, N. Jung, T. J. Sproule, S. Malarkannan, S. Joyce, and D. C. Roopenian Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease Blood, December 15, 2002; 100(13): 4259 - 4264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. N. Carayannopoulos, O. V. Naidenko, D. H. Fremont, and W. M. Yokoyama Cutting Edge: Murine UL16-Binding Protein-Like Transcript 1: A Newly Described Transcript Encoding a High-Affinity Ligand for Murine NKG2D J. Immunol., October 15, 2002; 169(8): 4079 - 4083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kasahara, Y. Watanabe, M. Sumasu, and T. Nagata A family of MHC class I-like genes located in the vicinity of the mouse leukocyte receptor complex PNAS, October 15, 2002; 99(21): 13687 - 13692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Ho, L. N. Carayannopoulos, J. Poursine-Laurent, J. Kinder, B. Plougastel, H. R. C. Smith, and W. M. Yokoyama Costimulation of Multiple NK Cell Activation Receptors by NKG2D J. Immunol., October 1, 2002; 169(7): 3667 - 3675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cerwenka, C. A. O'Callaghan, J. A. Hamerman, R. Yadav, W. Ajayi, D. C. Roopenian, S. Joyce, and L. L. Lanier Cutting Edge: The Minor Histocompatibility Antigen H60 Peptide Interacts with Both H-2Kb and NKG2D J. Immunol., April 1, 2002; 168(7): 3131 - 3134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. Frazer, R. D. Kluyver, G. R. Leggatt, H. Yang Guo, L. Dunn, O. White, C. Harris, A. Liem, and P. Lambert Tolerance or Immunity to a Tumor Antigen Expressed in Somatic Cells Can Be Determined by Systemic Proinflammatory Signals at the Time of First Antigen Exposure J. Immunol., December 1, 2001; 167(11): 6180 - 6187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Peng, E. Falck-Pedersen, and K. B. Elkon Variation in Adenovirus Transgene Expression between BALB/c and C57BL/6 Mice Is Associated with Differences in Interleukin-12 and Gamma Interferon Production and NK Cell Activation J. Virol., May 15, 2001; 75(10): 4540 - 4550. [Abstract] [Full Text]
|
|
|
|
|
|
E. Y. Choi, Y. Yoshimura, G. J. Christianson, T. J. Sproule, S. Malarkannan, N. Shastri, S. Joyce, and D. C. Roopenian Quantitative Analysis of the Immune Response to Mouse Non-MHC Transplantation Antigens In Vivo: The H60 Histocompatibility Antigen Dominates Over All Others J. Immunol., April 1, 2001; 166(7): 4370 - 4379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Mendoza, G. Villaflor, P. Eden, D. Roopenian, and N. Shastri Distinguishing Self from Nonself: Immunogenicity of the Murine H47 Locus Is Determined by a Single Amino Acid Substitution in an Unusual Peptide J. Immunol., April 1, 2001; 166(7): 4438 - 4445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Girardi, D. E. Oppenheim, C. R. Steele, J. M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R. E. Tigelaar, and A. C. Hayday Regulation of Cutaneous Malignancy by gamma delta T Cells Science, October 19, 2001; 294(5542): 605 - 609. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
